|
Jan 30
|
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics
|
|
Jan 29
|
Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates
|
|
Jan 28
|
Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
|
|
Jan 28
|
SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up
|
|
Jan 28
|
Sage rejects Biogen’s $469m takeover bid
|
|
Jan 27
|
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
|
|
Jan 27
|
Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal
|